| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.35 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.32 | 0.007 |